Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Delayed Toronto S.E.
Other stock markets
 15:57:51 23/05/2024 BST 		5-day change 1st Jan Change
0.475 CAD +1.06% Intraday chart for Satellos Bioscience Inc. -1.04% +10.47%
05-14 Satellos Bioscience Q1 Loss Widens Due To Higher Expenses; But Says "On track" to initiate Phase 1 First-in-human Clinical Trials Mid-2024 MT
03-27 Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SATELLOS BIOSCIENCE INC. Stock Satellos Bioscience Inc.
 38.77M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. Sector Chart